Home > > > Report Detail

Covid-19 Impact on Global Recombinant Plasma Proteins Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 12-May-2020
No. of pages: 90
Inquire Before Buying

For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation factors, anticoagulants, immunoglobulins, and albumin--essential to the treatment of serious congenital or acquired bleeding or immunological diseases. In the last 20 years, the application of recombinant technologies to mammalian cell cultures has made possible--although with some limitations in productivity, costs, and immunogenic risks-

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Plasma Proteins market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Plasma Proteins industry.

Based on our recent survey, we have several different scenarios about the Recombinant Plasma Proteins YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Plasma Proteins will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Plasma Proteins market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Plasma Proteins market in terms of revenue.

Players, stakeholders, and other participants in the global Recombinant Plasma Proteins market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Recombinant Plasma Proteins market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant Plasma Proteins market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Plasma Proteins market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Plasma Proteins market.

The following players are covered in this report:

- CSL Limited

- Shire (Takeda Pharmaceutical Company Limited)

- Octapharma

- Novo Nordisk

- Bayer

- Bioverativ Therapeutics, Inc. (Sanofi)

- Aptevo Therapeutics

- Pharming Group

- Pfizer

Recombinant Plasma Proteins Breakdown Data by Type

- Chinese Hamster Ovary (CHO) Cell Line

- Baby Hamster Kidney (BHK) Cell Line

- Human Embryonic Kidney (HEK) Cell Line

- Others

Recombinant Plasma Proteins Breakdown Data by Application

- Hemophilia A

- Hemophilia B

- Von Willebrand Disease

- Others

Covid-19 Impact on Global Recombinant Plasma Proteins Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Plasma Proteins Revenue
1.4 Market Analysis by Type
1.4.1 Global Recombinant Plasma Proteins Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chinese Hamster Ovary (CHO) Cell Line
1.4.3 Baby Hamster Kidney (BHK) Cell Line
1.4.4 Human Embryonic Kidney (HEK) Cell Line
1.4.5 Others
1.5 Market by Application
1.5.1 Global Recombinant Plasma Proteins Market Share by Application: 2020 VS 2026
1.5.2 Hemophilia A
1.5.3 Hemophilia B
1.5.4 Von Willebrand Disease
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Plasma Proteins Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Plasma Proteins Industry
1.6.1.1 Recombinant Plasma Proteins Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Plasma Proteins Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Plasma Proteins Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Recombinant Plasma Proteins Market Perspective (2015-2026)
2.2 Recombinant Plasma Proteins Growth Trends by Regions
2.2.1 Recombinant Plasma Proteins Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant Plasma Proteins Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant Plasma Proteins Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Recombinant Plasma Proteins Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant Plasma Proteins Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Plasma Proteins Players by Market Size
3.1.1 Global Top Recombinant Plasma Proteins Players by Revenue (2015-2020)
3.1.2 Global Recombinant Plasma Proteins Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant Plasma Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Plasma Proteins Market Concentration Ratio
3.2.1 Global Recombinant Plasma Proteins Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant Plasma Proteins Revenue in 2019
3.3 Recombinant Plasma Proteins Key Players Head office and Area Served
3.4 Key Players Recombinant Plasma Proteins Product Solution and Service
3.5 Date of Enter into Recombinant Plasma Proteins Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Recombinant Plasma Proteins Historic Market Size by Type (2015-2020)
4.2 Global Recombinant Plasma Proteins Forecasted Market Size by Type (2021-2026)
5 Recombinant Plasma Proteins Breakdown Data by Application (2015-2026)
5.1 Global Recombinant Plasma Proteins Market Size by Application (2015-2020)
5.2 Global Recombinant Plasma Proteins Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Recombinant Plasma Proteins Market Size (2015-2020)
6.2 Recombinant Plasma Proteins Key Players in North America (2019-2020)
6.3 North America Recombinant Plasma Proteins Market Size by Type (2015-2020)
6.4 North America Recombinant Plasma Proteins Market Size by Application (2015-2020)
7 Europe
7.1 Europe Recombinant Plasma Proteins Market Size (2015-2020)
7.2 Recombinant Plasma Proteins Key Players in Europe (2019-2020)
7.3 Europe Recombinant Plasma Proteins Market Size by Type (2015-2020)
7.4 Europe Recombinant Plasma Proteins Market Size by Application (2015-2020)
8 China
8.1 China Recombinant Plasma Proteins Market Size (2015-2020)
8.2 Recombinant Plasma Proteins Key Players in China (2019-2020)
8.3 China Recombinant Plasma Proteins Market Size by Type (2015-2020)
8.4 China Recombinant Plasma Proteins Market Size by Application (2015-2020)
9 Japan
9.1 Japan Recombinant Plasma Proteins Market Size (2015-2020)
9.2 Recombinant Plasma Proteins Key Players in Japan (2019-2020)
9.3 Japan Recombinant Plasma Proteins Market Size by Type (2015-2020)
9.4 Japan Recombinant Plasma Proteins Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Recombinant Plasma Proteins Market Size (2015-2020)
10.2 Recombinant Plasma Proteins Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant Plasma Proteins Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Plasma Proteins Market Size by Application (2015-2020)
11 India
11.1 India Recombinant Plasma Proteins Market Size (2015-2020)
11.2 Recombinant Plasma Proteins Key Players in India (2019-2020)
11.3 India Recombinant Plasma Proteins Market Size by Type (2015-2020)
11.4 India Recombinant Plasma Proteins Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Recombinant Plasma Proteins Market Size (2015-2020)
12.2 Recombinant Plasma Proteins Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant Plasma Proteins Market Size by Type (2015-2020)
12.4 Central & South America Recombinant Plasma Proteins Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 CSL Limited
13.1.1 CSL Limited Company Details
13.1.2 CSL Limited Business Overview and Its Total Revenue
13.1.3 CSL Limited Recombinant Plasma Proteins Introduction
13.1.4 CSL Limited Revenue in Recombinant Plasma Proteins Business (2015-2020))
13.1.5 CSL Limited Recent Development
13.2 Shire (Takeda Pharmaceutical Company Limited)
13.2.1 Shire (Takeda Pharmaceutical Company Limited) Company Details
13.2.2 Shire (Takeda Pharmaceutical Company Limited) Business Overview and Its Total Revenue
13.2.3 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Introduction
13.2.4 Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Proteins Business (2015-2020)
13.2.5 Shire (Takeda Pharmaceutical Company Limited) Recent Development
13.3 Octapharma
13.3.1 Octapharma Company Details
13.3.2 Octapharma Business Overview and Its Total Revenue
13.3.3 Octapharma Recombinant Plasma Proteins Introduction
13.3.4 Octapharma Revenue in Recombinant Plasma Proteins Business (2015-2020)
13.3.5 Octapharma Recent Development
13.4 Novo Nordisk
13.4.1 Novo Nordisk Company Details
13.4.2 Novo Nordisk Business Overview and Its Total Revenue
13.4.3 Novo Nordisk Recombinant Plasma Proteins Introduction
13.4.4 Novo Nordisk Revenue in Recombinant Plasma Proteins Business (2015-2020)
13.4.5 Novo Nordisk Recent Development
13.5 Bayer
13.5.1 Bayer Company Details
13.5.2 Bayer Business Overview and Its Total Revenue
13.5.3 Bayer Recombinant Plasma Proteins Introduction
13.5.4 Bayer Revenue in Recombinant Plasma Proteins Business (2015-2020)
13.5.5 Bayer Recent Development
13.6 Bioverativ Therapeutics, Inc. (Sanofi)
13.6.1 Bioverativ Therapeutics, Inc. (Sanofi) Company Details
13.6.2 Bioverativ Therapeutics, Inc. (Sanofi) Business Overview and Its Total Revenue
13.6.3 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Introduction
13.6.4 Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Proteins Business (2015-2020)
13.6.5 Bioverativ Therapeutics, Inc. (Sanofi) Recent Development
13.7 Aptevo Therapeutics
13.7.1 Aptevo Therapeutics Company Details
13.7.2 Aptevo Therapeutics Business Overview and Its Total Revenue
13.7.3 Aptevo Therapeutics Recombinant Plasma Proteins Introduction
13.7.4 Aptevo Therapeutics Revenue in Recombinant Plasma Proteins Business (2015-2020)
13.7.5 Aptevo Therapeutics Recent Development
13.8 Pharming Group
13.8.1 Pharming Group Company Details
13.8.2 Pharming Group Business Overview and Its Total Revenue
13.8.3 Pharming Group Recombinant Plasma Proteins Introduction
13.8.4 Pharming Group Revenue in Recombinant Plasma Proteins Business (2015-2020)
13.8.5 Pharming Group Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview and Its Total Revenue
13.9.3 Pfizer Recombinant Plasma Proteins Introduction
13.9.4 Pfizer Revenue in Recombinant Plasma Proteins Business (2015-2020)
13.9.5 Pfizer Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Recombinant Plasma Proteins Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant Plasma Proteins Revenue
Table 3. Ranking of Global Top Recombinant Plasma Proteins Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant Plasma Proteins Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chinese Hamster Ovary (CHO) Cell Line
Table 6. Key Players of Baby Hamster Kidney (BHK) Cell Line
Table 7. Key Players of Human Embryonic Kidney (HEK) Cell Line
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Recombinant Plasma Proteins Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Recombinant Plasma Proteins Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Recombinant Plasma Proteins Players to Combat Covid-19 Impact
Table 14. Global Recombinant Plasma Proteins Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Recombinant Plasma Proteins Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Recombinant Plasma Proteins Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Recombinant Plasma Proteins Market Share by Regions (2015-2020)
Table 18. Global Recombinant Plasma Proteins Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Recombinant Plasma Proteins Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Recombinant Plasma Proteins Market Growth Strategy
Table 24. Main Points Interviewed from Key Recombinant Plasma Proteins Players
Table 25. Global Recombinant Plasma Proteins Revenue by Players (2015-2020) (Million US$)
Table 26. Global Recombinant Plasma Proteins Market Share by Players (2015-2020)
Table 27. Global Top Recombinant Plasma Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Plasma Proteins as of 2019)
Table 28. Global Recombinant Plasma Proteins by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Recombinant Plasma Proteins Product Solution and Service
Table 31. Date of Enter into Recombinant Plasma Proteins Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Recombinant Plasma Proteins Market Size by Type (2015-2020) (Million US$)
Table 34. Global Recombinant Plasma Proteins Market Size Share by Type (2015-2020)
Table 35. Global Recombinant Plasma Proteins Revenue Market Share by Type (2021-2026)
Table 36. Global Recombinant Plasma Proteins Market Size Share by Application (2015-2020)
Table 37. Global Recombinant Plasma Proteins Market Size by Application (2015-2020) (Million US$)
Table 38. Global Recombinant Plasma Proteins Market Size Share by Application (2021-2026)
Table 39. North America Key Players Recombinant Plasma Proteins Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Recombinant Plasma Proteins Market Share (2019-2020)
Table 41. North America Recombinant Plasma Proteins Market Size by Type (2015-2020) (Million US$)
Table 42. North America Recombinant Plasma Proteins Market Share by Type (2015-2020)
Table 43. North America Recombinant Plasma Proteins Market Size by Application (2015-2020) (Million US$)
Table 44. North America Recombinant Plasma Proteins Market Share by Application (2015-2020)
Table 45. Europe Key Players Recombinant Plasma Proteins Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Recombinant Plasma Proteins Market Share (2019-2020)
Table 47. Europe Recombinant Plasma Proteins Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Recombinant Plasma Proteins Market Share by Type (2015-2020)
Table 49. Europe Recombinant Plasma Proteins Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Recombinant Plasma Proteins Market Share by Application (2015-2020)
Table 51. China Key Players Recombinant Plasma Proteins Revenue (2019-2020) (Million US$)
Table 52. China Key Players Recombinant Plasma Proteins Market Share (2019-2020)
Table 53. China Recombinant Plasma Proteins Market Size by Type (2015-2020) (Million US$)
Table 54. China Recombinant Plasma Proteins Market Share by Type (2015-2020)
Table 55. China Recombinant Plasma Proteins Market Size by Application (2015-2020) (Million US$)
Table 56. China Recombinant Plasma Proteins Market Share by Application (2015-2020)
Table 57. Japan Key Players Recombinant Plasma Proteins Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Recombinant Plasma Proteins Market Share (2019-2020)
Table 59. Japan Recombinant Plasma Proteins Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Recombinant Plasma Proteins Market Share by Type (2015-2020)
Table 61. Japan Recombinant Plasma Proteins Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Recombinant Plasma Proteins Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Recombinant Plasma Proteins Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Recombinant Plasma Proteins Market Share (2019-2020)
Table 65. Southeast Asia Recombinant Plasma Proteins Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Recombinant Plasma Proteins Market Share by Type (2015-2020)
Table 67. Southeast Asia Recombinant Plasma Proteins Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Recombinant Plasma Proteins Market Share by Application (2015-2020)
Table 69. India Key Players Recombinant Plasma Proteins Revenue (2019-2020) (Million US$)
Table 70. India Key Players Recombinant Plasma Proteins Market Share (2019-2020)
Table 71. India Recombinant Plasma Proteins Market Size by Type (2015-2020) (Million US$)
Table 72. India Recombinant Plasma Proteins Market Share by Type (2015-2020)
Table 73. India Recombinant Plasma Proteins Market Size by Application (2015-2020) (Million US$)
Table 74. India Recombinant Plasma Proteins Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Recombinant Plasma Proteins Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Recombinant Plasma Proteins Market Share (2019-2020)
Table 77. Central & South America Recombinant Plasma Proteins Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Recombinant Plasma Proteins Market Share by Type (2015-2020)
Table 79. Central & South America Recombinant Plasma Proteins Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Recombinant Plasma Proteins Market Share by Application (2015-2020)
Table 81. CSL Limited Company Details
Table 82. CSL Limited Business Overview
Table 83. CSL Limited Product
Table 84. CSL Limited Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 85. CSL Limited Recent Development
Table 86. Shire (Takeda Pharmaceutical Company Limited) Company Details
Table 87. Shire (Takeda Pharmaceutical Company Limited) Business Overview
Table 88. Shire (Takeda Pharmaceutical Company Limited) Product
Table 89. Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 90. Shire (Takeda Pharmaceutical Company Limited) Recent Development
Table 91. Octapharma Company Details
Table 92. Octapharma Business Overview
Table 93. Octapharma Product
Table 94. Octapharma Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 95. Octapharma Recent Development
Table 96. Novo Nordisk Company Details
Table 97. Novo Nordisk Business Overview
Table 98. Novo Nordisk Product
Table 99. Novo Nordisk Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 100. Novo Nordisk Recent Development
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Product
Table 104. Bayer Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 105. Bayer Recent Development
Table 106. Bioverativ Therapeutics, Inc. (Sanofi) Company Details
Table 107. Bioverativ Therapeutics, Inc. (Sanofi) Business Overview
Table 108. Bioverativ Therapeutics, Inc. (Sanofi) Product
Table 109. Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 110. Bioverativ Therapeutics, Inc. (Sanofi) Recent Development
Table 111. Aptevo Therapeutics Company Details
Table 112. Aptevo Therapeutics Business Overview
Table 113. Aptevo Therapeutics Product
Table 114. Aptevo Therapeutics Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 115. Aptevo Therapeutics Recent Development
Table 116. Pharming Group Business Overview
Table 117. Pharming Group Product
Table 118. Pharming Group Company Details
Table 119. Pharming Group Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 120. Pharming Group Recent Development
Table 121. Pfizer Company Details
Table 122. Pfizer Business Overview
Table 123. Pfizer Product
Table 124. Pfizer Revenue in Recombinant Plasma Proteins Business (2015-2020) (Million US$)
Table 125. Pfizer Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Plasma Proteins Market Share by Type: 2020 VS 2026
Figure 2. Chinese Hamster Ovary (CHO) Cell Line Features
Figure 3. Baby Hamster Kidney (BHK) Cell Line Features
Figure 4. Human Embryonic Kidney (HEK) Cell Line Features
Figure 5. Others Features
Figure 6. Global Recombinant Plasma Proteins Market Share by Application: 2020 VS 2026
Figure 7. Hemophilia A Case Studies
Figure 8. Hemophilia B Case Studies
Figure 9. Von Willebrand Disease Case Studies
Figure 10. Others Case Studies
Figure 11. Recombinant Plasma Proteins Report Years Considered
Figure 12. Global Recombinant Plasma Proteins Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Recombinant Plasma Proteins Market Share by Regions: 2020 VS 2026
Figure 14. Global Recombinant Plasma Proteins Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Recombinant Plasma Proteins Market Share by Players in 2019
Figure 17. Global Top Recombinant Plasma Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Plasma Proteins as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Recombinant Plasma Proteins Revenue in 2019
Figure 19. North America Recombinant Plasma Proteins Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Recombinant Plasma Proteins Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Recombinant Plasma Proteins Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Recombinant Plasma Proteins Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Recombinant Plasma Proteins Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Recombinant Plasma Proteins Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Recombinant Plasma Proteins Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. CSL Limited Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 28. Shire (Takeda Pharmaceutical Company Limited) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Shire (Takeda Pharmaceutical Company Limited) Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 30. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Octapharma Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 32. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Novo Nordisk Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 34. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bayer Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 36. Bioverativ Therapeutics, Inc. (Sanofi) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bioverativ Therapeutics, Inc. (Sanofi) Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 38. Aptevo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Aptevo Therapeutics Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 40. Pharming Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Pharming Group Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Revenue Growth Rate in Recombinant Plasma Proteins Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs